OpenFilings

PharmaCyte Biotech, Inc.

Form10-K

Report Period2026-04-30

Date Filed2026-07-29

Time Filed16:58:37

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

FORM 10-K FOR APRIL 2026
CORPORATE BYLAWS, AS AMENDED
LIST OF SUBSIDIARIES
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar